메뉴 건너뛰기




Volumn 36, Issue 10, 2009, Pages 2244-2249

Longterm survival among patients with scleroderma-associated pulmonary arterial hypertension treated with intravenous epoprostenol

Author keywords

6 Minute walk distance; Epoprostenol; Prostacyclin; Pulmonary arterial hypertension; Scleroderma; Therapy

Indexed keywords

PROSTACYCLIN;

EID: 70450162190     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.081277     Document Type: Article
Times cited : (78)

References (26)
  • 1
    • 5344233478 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension
    • Farber HW, Loscalzo J. Pulmonary arterial hypertension. N Engl J Med 2004;351:1655-1665.
    • (2004) N Engl J Med , vol.351 , pp. 1655-1665
    • Farber, H.W.1    Loscalzo, J.2
  • 2
    • 0031031440 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • Rubin LJ. Primary pulmonary hypertension. N Engl J Med 1997;336:111-117.
    • (1997) N Engl J Med , vol.336 , pp. 111-117
    • Rubin, L.J.1
  • 3
    • 0037623284 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • Runo JR, Loyd JE. Primary pulmonary hypertension. Lancet 2003;361:1533-1544.
    • (2003) Lancet , vol.361 , pp. 1533-1544
    • Runo, J.R.1    Loyd, J.E.2
  • 4
    • 0032578279 scopus 로고    scopus 로고
    • Primary pulmonary hypertension
    • Erratum, Lancet 1999;353:74
    • Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet 1998;352:719-725 [Erratum, Lancet 1999;353:74].
    • (1998) Lancet , vol.352 , pp. 719-725
    • Gaine, S.P.1    Rubin, L.J.2
  • 6
    • 33846316031 scopus 로고    scopus 로고
    • Pulmonary arterial hypertension in collagen disease: Experiences of the German Network for Systemic Scleroderma
    • Hunzelmann N, Riemekasten G. Pulmonary arterial hypertension in collagen disease: experiences of the German Network for Systemic Scleroderma. Dtsch Med Wochenschr 2006;131 Suppl 9:S325-7.
    • (2006) Dtsch Med Wochenschr , vol.131 , Issue.SUPPL. 9
    • Hunzelmann, N.1    Riemekasten, G.2
  • 10
    • 22244434954 scopus 로고    scopus 로고
    • The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologists (the UNCOVER study)
    • DOI 10.1002/art.21131
    • Wigley FM, Lima JA, Mayes M, McLain D, Chapin JL, Ward-Able C. The prevalence of undiagnosed pulmonary arterial hypertension in subjects with connective tissue disease at the secondary health care level of community-based rheumatologist (the UNCOVER study). Arthritis Rheum 2005;52:2125-2132. (Pubitemid 40994336)
    • (2005) Arthritis and Rheumatism , vol.52 , Issue.7 , pp. 2125-2132
    • Wigley, F.M.1    Lima, J.A.C.2    Mayes, M.3    McLain, D.4    Chapin, J.L.5    Ward-Able, C.6
  • 11
    • 0142187600 scopus 로고    scopus 로고
    • Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: Application of a registry approach
    • Mukerjee D, St. George D, Coleiro B, Knight C, Denton CP, Davar J, et al. Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach. Ann Rheum Dis 2003;62:1088-1093.
    • (2003) Ann Rheum Dis , vol.62 , pp. 1088-1093
    • Mukerjee, D.1    St George, D.2    Coleiro, B.3    Knight, C.4    Denton, C.P.5    Davar, J.6
  • 12
    • 0020520743 scopus 로고
    • Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis
    • Ungerer RG, Tashkin DP, Furst D, Clements PJ, Gong H, Bein M, et al. Prevalence and clinical correlates of pulmonary arterial hypertension in progressive systemic sclerosis. Am J Med 1983;75:65-74.
    • (1983) Am J Med , vol.75 , pp. 65-74
    • Ungerer, R.G.1    Tashkin, D.P.2    Furst, D.3    Clements, P.J.4    Gong, H.5    Bein, M.6
  • 13
    • 0017619874 scopus 로고
    • Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma)
    • Salneri R, Rodman GP, Leon DF, Shaver JA. Pulmonary hypertension in the CREST syndrome variant of progressive systemic sclerosis (scleroderma). Ann Intern Med 1977;86:394-399.
    • (1977) Ann Intern Med , vol.86 , pp. 394-399
    • Salneri, R.1    Rodman, G.P.2    Leon, D.F.3    Shaver, J.A.4
  • 14
    • 0036844311 scopus 로고    scopus 로고
    • Pulmonary hypertension in scleroderma spectrum of disease: Lack of bone morphogenetic protein receptor 2 mutations
    • Morse J, Barst R, Horn E, Cuervo N, Deng Z, Knowles J. Pulmonary hypertension in scleroderma spectrum of disease: Lack of bone morphogenic protein receptor 2 mutations. J Rheumatol 2002;29:2379-2381. (Pubitemid 35266029)
    • (2002) Journal of Rheumatology , vol.29 , Issue.11 , pp. 2379-2381
    • Morse, J.1    Barst, R.2    Horn, E.3    Cuervo, N.4    Deng, Z.5    Knowles, J.6
  • 15
    • 0033767899 scopus 로고    scopus 로고
    • Severe organ involvement in systemic sclerosis with diffuse scleroderma
    • Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum 2000;43:2437-2444.
    • (2000) Arthritis Rheum , vol.43 , pp. 2437-2444
    • Steen, V.D.1    Medsger Jr., T.A.2
  • 17
    • 0037331116 scopus 로고    scopus 로고
    • Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis
    • DOI 10.1378/chest.123.2.344
    • Kawut SM, Taichman DB, Archer-Chicko CL, Palevsky HI, Kimmel SE. Hemodynamics and survival in patients with pulmonary arterial hypertension related to systemic sclerosis. Chest 2003;123:344-350. (Pubitemid 36269414)
    • (2003) Chest , vol.123 , Issue.2 , pp. 344-350
    • Kawut, S.M.1    Taichman, D.B.2    Archer-Chicko, C.L.3    Palevsky, H.I.4    Kimmel, S.E.5
  • 18
    • 17144452827 scopus 로고    scopus 로고
    • Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: A randomized control trial
    • Badesch DB, Tapson VF, McGoon MD, Brundage BH, Rubin LJ, Wigley FM, et al. Continuous intravenous epoprostenol for pulmonary hypertension due to the scleroderma spectrum of disease: a randomized control trial. Ann Intern Med 2000;132:425-434.
    • (2000) Ann Intern Med , vol.132 , pp. 425-434
    • Badesch, D.B.1    Tapson, V.F.2    McGoon, M.D.3    Brundage, B.H.4    Rubin, L.J.5    Wigley, F.M.6
  • 19
    • 0029985117 scopus 로고    scopus 로고
    • Pulmonary hypertension in systemic sclerosis: An analysis of 17 patients
    • Koh ET, Lee P, Gladman DD, Abu-Shakra M. Pulmonary hypertension in systemic sclerosis: an analysis of 17 patients. Br J Rheumatol 1996;35:989-993. (Pubitemid 126719617)
    • (1996) Rheumatology , vol.35 , Issue.10 , pp. 989-993
    • Koh, E.T.1    Lee, P.2    Gladman, D.D.3    Abu-Shakra, M.4
  • 20
    • 34347266509 scopus 로고    scopus 로고
    • Changes in causes of death in systemic sclerosis, 1972-2002
    • Steen VD, Medsger TA. Changes in causes of death in systemic sclerosis, 1972-2002. Ann Rheum Dis 2007;66:940-944.
    • (2007) Ann Rheum Dis , vol.66 , pp. 940-944
    • Steen, V.D.1    Medsger, T.A.2
  • 23
    • 0032790301 scopus 로고    scopus 로고
    • Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: Results of a pilot study
    • DOI 10.1034/j.1399-3003.1999.13f20.x
    • Humbert M, Sanchez O, Fartoukh, M, Jagot JL, Le Gall C, Sitbon O, et al. Short-term and long-term epoprostenol (prostacyclin) therapy in pulmonary hypertension secondary to connective tissue diseases: results of a pilot study. Eur Respir J 1999;13:1351-1356. (Pubitemid 29357152)
    • (1999) European Respiratory Journal , vol.13 , Issue.6 , pp. 1351-1356
    • Humbert, M.1    Sanchez, O.2    Fartoukh, M.3    Jagot, J.-L.4    Le Gall, C.5    Sitbon, O.6    Parent, F.7    Simonneau, G.8
  • 24
    • 0030031888 scopus 로고    scopus 로고
    • A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension
    • Barst RJ, Rubin LJ, Long WA, McGoon MD, Rich S, Badesch DB, et al. A comparison of continuous intravenous epoprostenol (prostacyclin) with conventional therapy for primary pulmonary hypertension. N Engl J Med 1996;334:296-302.
    • (1996) N Engl J Med , vol.334 , pp. 296-302
    • Barst, R.J.1    Rubin, L.J.2    Long, W.A.3    McGoon, M.D.4    Rich, S.5    Badesch, D.B.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.